Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dolby Laboratories (DLB) EBT Margin (2016 - 2025)

Dolby Laboratories (DLB) has disclosed EBT Margin for 17 consecutive years, with 20.65% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 345.0% year-over-year to 20.65%, compared with a TTM value of 21.59% through Dec 2025, down 257.0%, and an annual FY2025 reading of 22.49%, down 204.0% over the prior year.
  • EBT Margin was 20.65% for Q4 2025 at Dolby Laboratories, up from 13.57% in the prior quarter.
  • Across five years, EBT Margin topped out at 33.4% in Q1 2024 and bottomed at 3.11% in Q3 2023.
  • Average EBT Margin over 5 years is 20.31%, with a median of 20.11% recorded in 2024.
  • The sharpest move saw EBT Margin crashed -1682bps in 2021, then surged 1821bps in 2023.
  • Year by year, EBT Margin stood at 26.0% in 2021, then rose by 15bps to 29.85% in 2022, then dropped by -14bps to 25.61% in 2023, then dropped by -6bps to 24.1% in 2024, then decreased by -14bps to 20.65% in 2025.
  • Business Quant data shows EBT Margin for DLB at 20.65% in Q4 2025, 13.57% in Q3 2025, and 17.59% in Q2 2025.